NFKB1 and neoplasm: Thus, our finding suggests that NF-κB and AP-1 may augment pro-survival signaling mechanism(s) in malignant cells and therapeutic targeting of these two potent transcription factors by FCN could abrogate tumor growth as well as survival (Figure 5).